Table 2.
Kentucky hospital and emergency department substance use disorder services offered
| Variable | Yes | No | Do not know | |||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| Pharmacy | ||||||
| Buprenorphine on hospital pharmacy’s formulary | 67 | 79% | 14 | 16% | 4 | 5% |
| Hospital has outpatient pharmacy with buprenorphine | 33 | 39% | 48 | 56% | 4 | 5% |
| ED has buprenorphine in Pixys medstation (n = 74)a | 28 | 38% | 43 | 58% | 3 | 4% |
| ED has own pharmacy | 6 | 7% | 79 | 93% | 0 | 0% |
| SUD Screening | ||||||
| ED has screening protocol to identify patients with substance use disorder | 37 | 44% | 43 | 51% | 5 | 6% |
| Protocol built into EHR (n = 37)b | 36 | 97% | 1 | 3% | 0 | 0% |
| Which patients are screened for SUD (n = 37)b | ||||||
| All | 25 | 68% | - | - | - | - |
| Some | 11 | 30% | - | - | - | - |
| None | 1 | 3% | - | - | - | - |
| MOUD Prescribing | ||||||
| ED has written protocol to prescribe buprenorphine to patients with OUD | 9 | 11% | 70 | 82% | 6 | 7% |
| ED facilitates home buprenorphine induction | 2 | 2% | 64 | 75% | 19 | 22% |
| Approximate percentage of ED providers who prescribed buprenorphine in past 12 months | ||||||
| None | 48 | 56% | - | - | - | - |
| 1 − 25% | 7 | 8% | - | - | - | - |
| 26 − 50% | 2 | 2% | - | - | - | - |
| 51 − 75% | 1 | 1% | - | - | - | - |
| Over 75% | 1 | 1% | - | - | - | - |
| Do not know | 26 | 31% | - | - | - | - |
| Require counseling, behavioral health intervention to receive MOUD | 7 | 8% | 52 | 61% | 26 | 31% |
| Peer supports and social services | ||||||
| Hospital utilizes peer supports in ED for patients with SUD | 11 | 13% | 68 | 80% | 6 | 7% |
| ED has direct access to hospital and/or ED social workers for patients with substance use disorder | 42 | 49% | 37 | 44% | - | - |
| Harm reduction standard protocol services c | ||||||
| Overdose education | 46 | 54% | - | - | - | - |
| Safer use education | 28 | 33% | - | - | - | - |
| No harm reduction services provided | 20 | 24% | - | - | - | - |
| Take-home naloxone | 20 | 24% | - | - | - | - |
| Other (please specify) | 10 | 12% | - | - | - | - |
| Co-prescribing naloxone with opioid prescriptions | 9 | 11% | - | - | - | - |
| Safer use supplies such as fentanyl test strips | 0 | 0% | - | - | - | - |
| Wound care kit | 0 | 0% | - | - | - | - |
aOf hospitals with Pixys Medstations (n = 74)
bOf hospitals with an SUD screening protocol (n = 37)
cSelect all that apply question, percentages may exceed 100%